Coenzyme Q10 in Post-Cardiac Arrest Cerebral Resuscitation
Cardiac Arrest, Sudden Cardiac Arrest
About this trial
This is an interventional treatment trial for Cardiac Arrest focused on measuring Cardiac Arrest, Post Cardiac Arrest, CoQ10, Ubiquinone, Post Arrest
Eligibility Criteria
Inclusion Criteria:
- Adult patients (age > 18 years)
- Comatose after CA with subsequent return of spontaneous circulation
Exclusion Criteria:
- Comatose status prior to CA
- CoQ10 therapy within one month prior to CA
- Pregnancy
Sites / Locations
- Beth Israel Deaconess Medical Center
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
CoenzymeQ10
Placebo
Patients will receive CoenzymeQ10 200mg three times per day for 7 days, until return to baseline neurologic status, or until death/discharge (whichever comes first). CoQ10 will be given through pre-existing NG or OG tube, and mixed with 20 ml of chocolate Ensure so as to blind investigators and staff.
Patients will receive 20 ml chocolate Ensure (as a placebo) three times per day for 7 days, until return to baseline neurologic status, or until death/discharge (whichever comes first). Placebo will be given through pre-existing NG or OG tube.